Company Information
CIN
Status
Date of Incorporation
14 January 1986
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
2,103,990
Authorised Capital
510,000,000
Directors
Ritik Vasant Jain
Director/Designated Partner
about 2 years ago
about 2 years ago
Aayush Sahebrao Khilari
Director/Designated Partner
over 2 years ago
over 2 years ago
Anjali Sahebrao Khilari
Director/Designated Partner
over 2 years ago
over 2 years ago
Sanket Khandu Varal
Director/Designated Partner
about 3 years ago
about 3 years ago
Khandu Vishnu Varal
Director/Designated Partner
almost 6 years ago
almost 6 years ago
Sahebrao Sukhdeo Khilari
Director/Designated Partner
about 6 years ago
about 6 years ago
Vasant Ghisulal Jain
Manager/Secretary
over 6 years ago
over 6 years ago
Chakradhar Bharat Chhaya
Director
about 15 years ago
about 15 years ago
Past Directors
Hitesh Jayantilal Vagadia
Cfo(kmp)
over 10 years ago
over 10 years ago
Jambunathan Srinivasa Iyer
Director
over 13 years ago
over 13 years ago
Devanand Parshottam Mojidra
Company Secretary
over 13 years ago
over 13 years ago
Abhay Prafulchandra Desai
Director
about 15 years ago
about 15 years ago
Bhumitra Vinodchandra Dholakia
Director
about 15 years ago
about 15 years ago
Smitesh Chandravadan Shah
Managing Director
over 15 years ago
over 15 years ago
Bharat Sukhlal Mehta
Director
over 15 years ago
over 15 years ago
Rajat Indulal Doshi
Director
about 16 years ago
about 16 years ago
Bansilal Dinanath Bhat
Director
over 18 years ago
over 18 years ago
Patents
The present invention relates to an improved process for the synthesis of (Z)-2-
(dibutylam ino)-1-(2,7-dichloro-9-(4-chlorobenzyl idene)-9H-fluoren-4-yl)ethanol, commonly known as Lumefantrine, an antimalarial drug.
More particularly, the present invention relates to improved processes for the selective synthesi...
The present invention relates to a novel process for preparation of bitter-less Erythromycin ethyl succinate using organic solvent selected from esters or ethers in formation of Erythromycin ethyl succinate from erythromycin base or in purification of Erythromycin ethyl succinate. The present invention also relates ...
The present invention relates to a process for preparation of substantially pure N-9 alkylated isomer N2-Acetyl-9-(l,3-diacetoxy-2-propoxymethyl)guanine and to use this intermediate for the preparation of Ganciclovir of sufficient purity.
The present invention relates to an improved process for the preparation of Azithromycin monohydrate. More particularly, the present invention relates to a simple and industrially scalable process for preparation of stable Azithromycin monohydrate having residual solvent content between 0 to 200 ppm.
...
The present invention relates to a simple, eco friendly and an improved process for preparation of Sarpogrelate of Formula I and its salts employing water as a solvent.
The present invention provides an improved and commercially viable process for preparation of famciclovir of compound of formula (I), in high purity and good yield
which comprises,
isolation of desired N9 isomer of triester of formula (II)
by precipitating it with a suitable solvent followed by direct reduc...
The present invention related to the process for preparation of alogliptin benzoate (I) and its pharmaceutically acceptable acid addition salt.
The present invention provides an improved process for preparation of Maraviroc of Formula I by reductive amination using ammonium salt as a reducing agent.
The present invention relates to an improved in-situ process for the preparation of Valsartan intermediate, N-[2"-(lH-tetrazol-5yI) biphenyl-4-yl) methyl] N-valeryl-(L)-valine benzylester. More particularly, the present invention relates to an improved, cost effective and industrially feasible in-situ process for th...
The present invention relates to an improved process for preparation of stable and pure Clopidogrel bisulfate polymorphic form I from Clopidogrel base.
The present invention is to provide a novel process for the preparation of ethers of dihydroartemisinin, more particularly artemether and arteether containing more than 99% of P- isomer in higher yield with a simple isolation procedure and by using a pro-acid catalyst in very small amount.
The present invention relates to an improved process for the preparation of Valsartan.
A process for preparation of telmisartan comprising the steps of
condensing 2-n-propyl-4-methyl-6-(1"-methylbenzimidazole-2-yl)benzimidazole
with alkyl ester of 4"-bromomethylbiphenyl-2-carboxylic acid in presence of a
base and an alcoholic solvent to obtain a telmisartan alkylester intermediate and further hy...
The present invention discloses a process for the preparation of substituted aryl alkylamine compounds comprising the step of,reducing the substituted aryl acetonitrile substrate using Raney nickel catalyst at lower substrate/catalyst ratio of 20:1 to 6:1 with higher sybstrate concentration, at ramped temperature/ p...
The present invention relates to an efficient one pot process for the synthesis of (Z)-2-(dibutyiamino)-1 -(2, 7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl) ethanol of formula-I, commonly known as lumefantrine (formerly known as Benflumetol). More particularly, the present invention provides an improved one po...
The present invention relates to an improved process for the preparation of Sartans and pharmaceutically acceptable salts thereof from the cyano compounds.
A novel process for the production of valproic acid of Formula I, comprising, heating a reaction mixture comprising di-n-propylmalonic acid of Formula (II), metal catalyst in the form of its salt or oxide, and (3) a polar organic solvent, alone or in combination with one another, at 60° to 100°C for 6 to 15 hours to...
A process for the preparation of unsymmetrical biaryl compounds of Formula I wherein, R is alkyl, R’ is cyano, protected or unprotected tetrazole, or –H/C=NR” wherein, R” is alkyl, aryl, aralkyl or alkoxy, said process comprising, reacting Grignard reagent of Formula II wherein, R is alkyl; X is halogen with an aryl...
The present invention relates to a novel process for the synthesis of piperaquine base of formula IV and its intermediate 7-chloro-4-(piperazin-l-yl)quinoline. The present invention also relates to an improved process for the synthesis of piperaquine tetraphosphate tetrahydrate of formula I.
The present invention f...
The present invention relates to a novel process for preparation of eszopiclone of
formula (II) by reacting racemic zopiclone with an optically active acid in presence of water. The present invention also relates to a process for the purification of dextroisomer of optically active salt of zopiclone and eszopiclon...
The present invention provides an improved process for the preparation of mercaptocarboxylates of trimethylolpropane and pentaerythritol (polythiols) comprising reacting mercaptoalkanoic acid with trimethylolpropane and pentaerythritol respectively in the presence of a cation exchange resin as a catalyst in a suitab...
The present invention relates to a novel process for effective alkylation of key drug intermediates or their salts using substituted or unsubstituted Imidazole moiety as a catalyst.
Disclosed herein is process for the separation of 4-bromomethyl-2’-substituted biphenyls of Formula II from 4,4-dibromomethyl-2’-substituted biphenyls of Formula III and 4-methyl-2’-substituted biphenyl of Formula I by stirring a crude reaction mixture comprising compounds of formula I, II and III in suitable orga...
The present invention relates to an improved and efficient process for the preparation of 2-n-butyl-3-[[2"-(lH-tetrazol-5-yl)[l,l"-biphenyl]-4-yl]methyl]-l,3-diazaspiro[4.4]non-l-en-4-one of formula I, also known as "Irbesartan".
H3C
Formula I
In particular, the present invention provides an improved process f...
The present invention relates to a novel water based process for the preparation of racemic, levorotatory or dextrorotatory diphenylmethyl piperazines.
ABSTRACT
The present invention relates to a novel process for preparation of heterocyclic N-substituted alkylamines of formula I, by reacting appropriate amine with protected halo-substituted alkyl amine salt in the presence of catalyst and water as a solvent. The present invention also relates to a novel one-pot p...
The present invention relates to an improved process for the preparation of
ethers of dihydroartemisinin, more particularly artemether and arteether
containing more than 99% of β isomer from dihydroartemisinin by reacting
dihydroartemisinin with trialkyl orthoformate in the presence of a dry cation
exchange ...
The present invention relates to a novel process for desalination of Lisinopril (N2-t(S)-l-Carboxy-3-phenylpropyI]-L-lysyI-L-proline) of formula I, which is a very useful antihypertensive agent.
In particular, there is provided a novel process for removing the salts from Lisinopril of formula I by partitioning t...
The present invention relates to an improved and commercially viable process for preparation of L-valine benzyl ester p-toluenesulfonate wherein said product is isolated employing anti-solvent selected from a cycloalkane or branched aliphatic ether.
The present invention relates to a novel one pot process for preparation of N-carbamate of 3-oxopiperazine of formula I, particularly benzyl-3-oxopiperazine-l-carboxylate and tert-butyl-3-oxopiperazine-l-carboxylate, from ethylene diamine,
wherein R represents a benzyl group or a tert-butyl group.
...
The present invention relates to a novel process for the preparation of 4-(2-(dimethylamino)-l-(l-hydroxycyclohexyl) ethyl) phenol, commonly known as O-desmethylvenlafaxine of formula I and its pharmaceutically acceptable salts thereof.The present invention also relates to the novel process for the preparation of O-...
The present invention relates to a novel process for the liberation of Erythromycin from Erythromycin salts such as Erythromycin thiocyanate using water as a solvent in presence of a base. Erythromycin obtained by processes of present invention has purity of more than 95%.
A novel single step process for the synthesis of venlafaxine of formula I and N-desmethylvenlafaxine of formula II from 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile [cyano-intermediate] of formula V comprising reacting 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile with an alkylamine and/or its s...
The present invention related to a novel process for preparation of Mirabegron of formula (I) and its intermediate.
The present relates to an improved and commercially viable in-situ process for preparation of N- [2" -(1 -triphenylmethyl-tetrazol-5-yl) biphenyl-4-yl)methyl-N-valeryl-(L)-valine benzyl ester, an intermediate of Valsartan (Formula I).
The present invention further relates to an improved process for preparation o...
Charges
31 March 2014
The Jammu And Kashmir Bank Limited
50 Crore
18 February 2013
Uco Bank
20 Crore
17 January 2013
Export-import Bank Of India
27 Crore
05 October 2012
State Bank Of Travancore
60 Crore
10 July 2012
Encore Asset Reconstruction Company Private Limited
9 Crore
04 July 2012
Bank Of Maharashtra
10 Crore
04 July 2012
Bank Of Maharashtra
15 Crore
23 June 2012
State Bank Of Bikaner And Jaipur
40 Crore
23 May 2012
State Bank Of Bikaner And Jaipur
20 Crore
15 December 2011
Export-import Bank Of India
25 Crore
15 December 2011
Export-import Bank Of India
5 Crore
11 August 2010
State Bank Of India
476 Crore
17 March 2004
State Bank Of India
3 Crore
06 June 2001
State Bank Of India
258 Crore
19 June 2012
Sbicap Trustee Company Limited
645 Crore
18 May 2011
Sbi Global Factors Limited
27 Crore
29 January 2004
Sbi Factor And Commercial Services Ltd.
4 Crore
04 December 2012
Corporation Bank
40 Crore
29 January 2013
State Bank Of Bikaner And Jaipur
23 Lak
29 March 2012
Bank Of India
40 Crore
06 February 2007
Export-import Bank Of India
13 Crore
09 February 2010
Punjab National Bank
86 Crore
09 February 2010
Punjab National Bank
20 Crore
09 February 2010
Punjab National Bank
19 Crore
13 June 2011
Bank Of Bahrain And Kuwait B S C
15 Crore
26 May 2011
State Bank Of Mauritius
10 Crore
28 October 2009
Idbi Bank Limited
43 Crore
11 March 2010
State Bank Of Hyderabad
20 Crore
03 September 2009
Oriental Bank Of Commerce Limited
25 Crore
03 October 2011
Allahabad Bank
40 Crore
03 August 2010
State Bank Of Patiala
30 Crore
30 January 2010
State Bank Of Patiala
50 Crore
03 August 2010
State Bank Of Patiala
40 Crore
04 June 2009
State Bank Of Mysore
30 Crore
13 September 2010
State Bank Of Mysore
30 Crore
26 July 2011
Canara Bank
30 Crore
08 October 2011
Ing Vysya Bank Limited
25 Crore
13 October 2006
Bank Of India
13 Crore
30 May 2007
Standard Chartered Bank
20 Crore
02 December 2005
Export-import Bank Of India
10 Crore
25 October 2007
Icici Bank Limited
6 Crore
17 November 2007
Icici Bank Limited
20 Crore
13 June 2008
Kotak Mahindra Bank Limited
3 Crore
16 January 2005
Icici Bank Limited
30 Crore
29 October 2005
Hdfc Bank Limited
23 Crore
03 April 1999
State Bank Of India
10 Crore
03 April 1999
State Bank Of India
9 Crore
21 February 2008
Axis Bank Limited
10 Crore
23 September 2006
Sicom Limited
4 Crore
27 July 2021
Abhyudaya Co-operative Bank Limited
1 Lak
09 January 2020
Abhyudaya Co-operative Bank Limited
60 Crore
16 November 2019
Abhyudaya Co-operative Bank Limited
25 Crore
16 November 2019
Abhyudaya Co-operative Bank Limited
30 Crore
02 January 2020
Nkgsb Co-operative Bank Ltd.
1 Crore
13 November 2019
Nkgsb Co-operative Bank Ltd.
1 Crore
21 December 2019
Nkgsb Co-operative Bank Ltd.
1 Crore
17 July 2019
Nkgsb Co-operative Bank Ltd.
1 Crore
24 July 2019
Nkgsb Co-operative Bank Ltd.
94 Lak
10 January 2023
Hdfc Bank Limited
0
09 January 2020
Abhyudaya Co-operative Bank Limited
0
21 December 2019
Others
0
16 November 2019
Abhyudaya Co-operative Bank Limited
0
16 November 2019
Abhyudaya Co-operative Bank Limited
0
24 July 2019
Others
0
10 July 2012
Others
0
03 August 2010
State Bank Of Patiala
0
13 November 2019
Others
0
02 January 2020
Others
0
27 July 2021
Abhyudaya Co-operative Bank Limited
0
17 July 2019
Others
0
13 June 2008
Kotak Mahindra Bank Limited
0
21 February 2008
Axis Bank Limited
0
13 October 2006
Bank Of India
0
23 September 2006
Sicom Limited
0
29 March 2012
Bank Of India
0
15 December 2011
Export-import Bank Of India
0
15 December 2011
Export-import Bank Of India
0
11 August 2010
State Bank Of India
0
13 September 2010
State Bank Of Mysore
0
16 January 2005
Icici Bank Limited
0
26 May 2011
State Bank Of Mauritius
0
05 October 2012
State Bank Of Travancore
0
04 December 2012
Corporation Bank
0
04 June 2009
State Bank Of Mysore
0
29 January 2013
State Bank Of Bikaner And Jaipur
0
03 September 2009
Oriental Bank Of Commerce Limited
0
31 March 2014
The Jammu And Kashmir Bank Limited
0
29 October 2005
Hdfc Bank Limited
0
02 December 2005
Export-import Bank Of India
0
03 April 1999
State Bank Of India
0
28 October 2009
Idbi Bank Limited
0
29 January 2004
Sbi Factor And Commercial Services Ltd.
0
08 October 2011
Ing Vysya Bank Limited
0
06 June 2001
State Bank Of India
0
17 March 2004
State Bank Of India
0
03 April 1999
State Bank Of India
0
18 February 2013
Uco Bank
0
17 January 2013
Export-import Bank Of India
0
04 July 2012
Bank Of Maharashtra
0
04 July 2012
Bank Of Maharashtra
0
23 June 2012
State Bank Of Bikaner And Jaipur
0
19 June 2012
Sbicap Trustee Company Limited
0
23 May 2012
State Bank Of Bikaner And Jaipur
0
03 October 2011
Allahabad Bank
0
26 July 2011
Canara Bank
0
18 May 2011
Sbi Global Factors Limited
0
13 June 2011
Bank Of Bahrain And Kuwait B S C
0
11 March 2010
State Bank Of Hyderabad
0
09 February 2010
Punjab National Bank
0
09 February 2010
Punjab National Bank
0
09 February 2010
Punjab National Bank
0
30 January 2010
State Bank Of Patiala
0
17 November 2007
Icici Bank Limited
0
25 October 2007
Icici Bank Limited
0
30 May 2007
Standard Chartered Bank
0
06 February 2007
Export-import Bank Of India
0
03 August 2010
State Bank Of Patiala
0
10 January 2023
Hdfc Bank Limited
0
09 January 2020
Abhyudaya Co-operative Bank Limited
0
21 December 2019
Others
0
16 November 2019
Abhyudaya Co-operative Bank Limited
0
16 November 2019
Abhyudaya Co-operative Bank Limited
0
24 July 2019
Others
0
10 July 2012
Others
0
03 August 2010
State Bank Of Patiala
0
13 November 2019
Others
0
02 January 2020
Others
0
27 July 2021
Abhyudaya Co-operative Bank Limited
0
17 July 2019
Others
0
13 June 2008
Kotak Mahindra Bank Limited
0
21 February 2008
Axis Bank Limited
0
13 October 2006
Bank Of India
0
23 September 2006
Sicom Limited
0
29 March 2012
Bank Of India
0
15 December 2011
Export-import Bank Of India
0
15 December 2011
Export-import Bank Of India
0
11 August 2010
State Bank Of India
0
13 September 2010
State Bank Of Mysore
0
16 January 2005
Icici Bank Limited
0
26 May 2011
State Bank Of Mauritius
0
05 October 2012
State Bank Of Travancore
0
04 December 2012
Corporation Bank
0
04 June 2009
State Bank Of Mysore
0
29 January 2013
State Bank Of Bikaner And Jaipur
0
03 September 2009
Oriental Bank Of Commerce Limited
0
31 March 2014
The Jammu And Kashmir Bank Limited
0
29 October 2005
Hdfc Bank Limited
0
02 December 2005
Export-import Bank Of India
0
03 April 1999
State Bank Of India
0
28 October 2009
Idbi Bank Limited
0
29 January 2004
Sbi Factor And Commercial Services Ltd.
0
08 October 2011
Ing Vysya Bank Limited
0
06 June 2001
State Bank Of India
0
17 March 2004
State Bank Of India
0
03 April 1999
State Bank Of India
0
18 February 2013
Uco Bank
0
17 January 2013
Export-import Bank Of India
0
04 July 2012
Bank Of Maharashtra
0
04 July 2012
Bank Of Maharashtra
0
23 June 2012
State Bank Of Bikaner And Jaipur
0
19 June 2012
Sbicap Trustee Company Limited
0
23 May 2012
State Bank Of Bikaner And Jaipur
0
03 October 2011
Allahabad Bank
0
26 July 2011
Canara Bank
0
18 May 2011
Sbi Global Factors Limited
0
13 June 2011
Bank Of Bahrain And Kuwait B S C
0
11 March 2010
State Bank Of Hyderabad
0
09 February 2010
Punjab National Bank
0
09 February 2010
Punjab National Bank
0
09 February 2010
Punjab National Bank
0
30 January 2010
State Bank Of Patiala
0
17 November 2007
Icici Bank Limited
0
25 October 2007
Icici Bank Limited
0
30 May 2007
Standard Chartered Bank
0
06 February 2007
Export-import Bank Of India
0
03 August 2010
State Bank Of Patiala
0
Documents
Form CHG-4-01102020_signed
Letter of the charge holder stating that the amount has been satisfied-29092020
Letter of the charge holder stating that the amount has been satisfied-29092020
Form PAS-3-31082020_signed
Copy of Board or Shareholders? resolution-29082020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-29082020
Form PAS-3-18082020_signed
Copy of Board or Shareholders? resolution-18082020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-18082020
Form MGT-14-07082020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-07082020
Optional Attachment-(1)-14072020
Form DIR-12-14072020_signed
Optional Attachment-(1)-01072020
Evidence of cessation;-01072020
Form DIR-12-01072020_signed
Form SH-7-15042020-signed
Form MGT-14-11042020-signed
Form PAS-3-08042020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-08042020
Copy of Board or Shareholders? resolution-08042020
Altered articles of association-08042020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-08042020
Altered memorandum of association-08042020
Optional Attachment-(1)-08042020
Copy of the resolution for alteration of capital;-08042020
Form MGT-14-07042020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-07042020
Form SH-7-19032020-signed
Form SH-7-03032020-signed
